[
  {
    "ts": null,
    "headline": "MetLife CEO Michel Khalaf and CFO John McCallion to Speak at the 2025 Keefe, Bruyette & Woods Insurance Conference",
    "summary": "NEW YORK, August 13, 2025--MetLife, Inc. (NYSE: MET) today announced that Michel Khalaf, president and chief executive officer, and John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, will participate in a fireside chat at the 2025 Keefe, Bruyette & Woods Annual Insurance Conference on Wednesday, Sept. 3, 2025, from 10:05 a.m. to 10:45 a.m. (ET).",
    "url": "https://finnhub.io/api/news?id=4ef6b81d6d81750f5740c5a71ae5984f404acbe8440aebfce646cbbf888bbc09",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755116100,
      "headline": "MetLife CEO Michel Khalaf and CFO John McCallion to Speak at the 2025 Keefe, Bruyette & Woods Insurance Conference",
      "id": 136340039,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MET",
      "source": "Yahoo",
      "summary": "NEW YORK, August 13, 2025--MetLife, Inc. (NYSE: MET) today announced that Michel Khalaf, president and chief executive officer, and John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, will participate in a fireside chat at the 2025 Keefe, Bruyette & Woods Annual Insurance Conference on Wednesday, Sept. 3, 2025, from 10:05 a.m. to 10:45 a.m. (ET).",
      "url": "https://finnhub.io/api/news?id=4ef6b81d6d81750f5740c5a71ae5984f404acbe8440aebfce646cbbf888bbc09"
    }
  },
  {
    "ts": null,
    "headline": "MetLife Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
    "summary": "MetLife Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=46d62c43dab22f3c552f2f3c6d81b44b161c326dcf95e889f7a66c33c8891dbb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755103680,
      "headline": "MetLife Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
      "id": 136359898,
      "image": "",
      "related": "MET",
      "source": "MarketWatch",
      "summary": "MetLife Inc. stock underperforms Wednesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=46d62c43dab22f3c552f2f3c6d81b44b161c326dcf95e889f7a66c33c8891dbb"
    }
  },
  {
    "ts": null,
    "headline": "The Top 5 Analyst Questions From MetLife’s Q2 Earnings Call",
    "summary": "MetLife’s second quarter was marked by a 2.9% negative market reaction, reflecting investor concerns over results that fell short of Wall Street expectations. Management cited less favorable underwriting, especially in Group Benefits, and lower variable investment income as primary headwinds. CEO Michel Khalaf described the underwriting experience as “within normal fluctuations,” but acknowledged challenges in both life and non-medical health, while also noting strong momentum in Asia and Latin",
    "url": "https://finnhub.io/api/news?id=cb71fce63a118f92d4241d2d5f401cd997e6ec1dffbe464102d3c4d7f6bf6d69",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755063780,
      "headline": "The Top 5 Analyst Questions From MetLife’s Q2 Earnings Call",
      "id": 136328649,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MET",
      "source": "Yahoo",
      "summary": "MetLife’s second quarter was marked by a 2.9% negative market reaction, reflecting investor concerns over results that fell short of Wall Street expectations. Management cited less favorable underwriting, especially in Group Benefits, and lower variable investment income as primary headwinds. CEO Michel Khalaf described the underwriting experience as “within normal fluctuations,” but acknowledged challenges in both life and non-medical health, while also noting strong momentum in Asia and Latin",
      "url": "https://finnhub.io/api/news?id=cb71fce63a118f92d4241d2d5f401cd997e6ec1dffbe464102d3c4d7f6bf6d69"
    }
  }
]